Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., has announced major updates to its spatial biology product line, introducing a new class of spatial technology designed to make single-cell spatial analysis more accessible, versatile, and integrative.…
Thermo Fisher Scientific, the world leader in serving science, has introduced a groundbreaking laboratory developed test (LDT) designed to improve the detection and assessment of lung transplant rejection and injury. The new Molecular Microscope® Diagnostic System for Lung (MMDx® Lung)…
Charles River Laboratories International, Inc. and Toxys have announced a strategic collaboration to expand access to ReproTracker®, a cutting-edge, human stem cell-based in vitro assay designed to identify developmental toxicity hazards in pharmaceuticals and chemicals. The partnership aims to accelerate…
biomodal, a leading omics-based life sciences technology and analytics company, has announced the launch of its Certified Service Provider (CSP) Program, a new global initiative aimed at expanding access to its duet multiomics sequencing technologies. The program brings together a…
The IMA Group (IMA), a leading national provider of medical and psychological evaluations and clinical research services, has announced the acquisition of Chicago Research Center (CRC), an independent, Chicago-based clinical research site with a strong reputation in central nervous system…
Calira, formerly known as Clustermarket, has announced a major rebrand and the appointment of Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), as a non-executive director and investor. The move underscores Calira’s strategy to strengthen its position…
Kernal Biologics, Inc., a venture-backed TechBio company transforming the treatment landscape through mRNA-based in vivo cell programming, announced it has been awarded up to $48 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The award comes…
Hesperos, Inc., a global leader in developing Human-on-a-Chip® (HoaC) technology for improving preclinical testing across pharmaceuticals, food, cosmetics, and chemicals, has announced a groundbreaking advancement in neuroscience research. In collaboration with Bayer Consumer Health, the company has unveiled the first…
BioSkryb Genomics, a leader in single-cell and ultra–low-input multiomic technologies, has announced the launch of its ResolveSEQ LongRead Early Access Program, in collaboration with Eremid® Genomic Services, a high-complexity genomics contract research organization (CRO) and Certified Service Provider (CSP) for…
Membrion, a pioneering ceramic desalination membrane innovator, has successfully completed a $20 million Series B1 funding round, marking a significant milestone in its mission to revolutionize industrial water management. The round was anchored by leading climate-tech and materials investors, including…